News
Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads ...
Researchers reviewed the clinical characteristics of patients taking GLP-1 receptor agonists who develop NAION.
Luke Jackson left his May 12 appearance due to a finger injury, suffered when he was struck by a batted ball. If Jackson misses additional time, the Rangers could turn to Chris Martin to save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results